Concepedia
Statistics
Publications
9
Citations
340
H-Index
Active since
1998
Affiliations
Janssen (United States)(Current)
Janssen (Belgium)
Mount Sinai Medical Center
Johnson & Johnson (United States)
Henry Richards is an author at Janssen (United States) specializing in pharmacology, medicine, and pharmacotherapy.
Publications per year
1998–2018
Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer
John V. Heymach, David H. Johnson, Fadlo R. Khuri et al. · Annals of Oncology · 2004 · 89 citations · Full text
Medicine, Oncology, Pharmacology +10
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease
Alan Baseman, Klaus Häger, Jeffrey S. Nye et al. · Neuropsychiatric Disease and Treatment · 2014 · 66 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial
David G. Lange, Henry Richards, Joseph A. Guarnieri et al. · Journal of the American Academy of Dermatology · 1998 · 66 citations
Pharmacy, Dermatology, Pharmacotherapy +9
A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies.
Amita Patnaik, S. Gail Eckhardt, Elżbieta Izbicka et al. · PubMed · 2003 · 33 citations
Pharmacy, Pharmacokinetics, Pharmacology +10
Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study
Shiying Yu, Wei Feng Shen, Lu Yu et al. · Journal of Pain · 2014 · 25 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
1–5 of 9